Keytruda shows promise in helping patients with ‘untreatable’ prostate cancer

Merck and Co. reported positive results from several studies this week involving its major immunotherapy drug, Keytruda.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news